COPPOLINO, GIUSEPPE
 Distribuzione geografica
Continente #
EU - Europa 3.612
NA - Nord America 3.337
AS - Asia 1.638
SA - Sud America 533
AF - Africa 46
Continente sconosciuto - Info sul continente non disponibili 2
OC - Oceania 2
Totale 9.170
Nazione #
US - Stati Uniti d'America 3.268
RU - Federazione Russa 1.879
SG - Singapore 684
CN - Cina 501
BR - Brasile 473
IE - Irlanda 457
SE - Svezia 442
DE - Germania 218
HK - Hong Kong 181
UA - Ucraina 136
FR - Francia 120
FI - Finlandia 100
VN - Vietnam 89
GB - Regno Unito 83
IT - Italia 75
IN - India 45
AR - Argentina 26
CA - Canada 25
MX - Messico 24
BD - Bangladesh 22
PL - Polonia 21
CZ - Repubblica Ceca 19
IQ - Iraq 16
TR - Turchia 15
ZA - Sudafrica 15
ES - Italia 13
BE - Belgio 12
MA - Marocco 12
JP - Giappone 11
AT - Austria 9
ID - Indonesia 9
CO - Colombia 7
EC - Ecuador 7
AE - Emirati Arabi Uniti 6
LV - Lettonia 6
PY - Paraguay 6
VE - Venezuela 6
PK - Pakistan 5
SA - Arabia Saudita 5
UZ - Uzbekistan 5
AZ - Azerbaigian 4
DO - Repubblica Dominicana 4
EG - Egitto 4
IL - Israele 4
IR - Iran 4
KE - Kenya 4
KZ - Kazakistan 4
LT - Lituania 4
NP - Nepal 4
AL - Albania 3
GT - Guatemala 3
GY - Guiana 3
JM - Giamaica 3
NI - Nicaragua 3
NL - Olanda 3
PA - Panama 3
PS - Palestinian Territory 3
TN - Tunisia 3
AU - Australia 2
BN - Brunei Darussalam 2
CI - Costa d'Avorio 2
CR - Costa Rica 2
GR - Grecia 2
KG - Kirghizistan 2
KW - Kuwait 2
LB - Libano 2
MD - Moldavia 2
MY - Malesia 2
NO - Norvegia 2
OM - Oman 2
PH - Filippine 2
QA - Qatar 2
SN - Senegal 2
UY - Uruguay 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AO - Angola 1
BG - Bulgaria 1
BO - Bolivia 1
CH - Svizzera 1
CL - Cile 1
CY - Cipro 1
DK - Danimarca 1
EU - Europa 1
GI - Gibilterra 1
HN - Honduras 1
JO - Giordania 1
KR - Corea 1
LA - Repubblica Popolare Democratica del Laos 1
ME - Montenegro 1
MN - Mongolia 1
NG - Nigeria 1
PE - Perù 1
PT - Portogallo 1
RW - Ruanda 1
SV - El Salvador 1
TG - Togo 1
Totale 9.170
Città #
Ashburn 559
Moscow 487
Dublin 457
Chandler 439
Singapore 365
Jacksonville 310
Dallas 277
Nyköping 222
Beijing 195
Hong Kong 180
San Jose 166
The Dalles 99
Dearborn 87
Princeton 69
Lauterbourg 67
Los Angeles 65
Cambridge 62
Medford 60
Munich 59
Des Moines 58
Ann Arbor 57
New York 50
Boardman 45
Ho Chi Minh City 34
São Paulo 33
Buffalo 26
Bremen 24
Frankfurt am Main 23
Tianjin 21
Turku 21
Redondo Beach 20
Hanoi 19
San Mateo 19
Lancaster 18
Orem 18
Santa Clara 18
Belo Horizonte 16
Helsinki 16
Seattle 16
Warsaw 16
Brooklyn 15
Brno 14
Chennai 14
Council Bluffs 14
Woodbridge 14
Jinan 13
Montreal 13
Brussels 12
Nanjing 12
Brasília 11
Denver 11
Düsseldorf 10
Johannesburg 10
Shanghai 10
Shenyang 10
Tokyo 10
Wilmington 10
Dhaka 9
London 9
Porto Alegre 9
Rio de Janeiro 9
Bexley 8
Boston 8
Chicago 8
Houston 8
Leawood 8
Milan 8
Ningbo 8
Poplar 8
Stockholm 8
Taizhou 8
Atlanta 7
Campinas 7
Curitiba 7
Falls Church 7
Haikou 7
Pune 7
Recife 7
Augusta 6
Guangzhou 6
Hebei 6
Hefei 6
Mexico City 6
Nuremberg 6
Querétaro 6
Riga 6
San Francisco 6
Asunción 5
Baghdad 5
Goiânia 5
Hangzhou 5
Jiaxing 5
Manchester 5
Nanchang 5
Shenzhen 5
Siracusa 5
Tashkent 5
Zhengzhou 5
Ankara 4
Baku 4
Totale 5.278
Nome #
A brief "update" on renal effects of caffeine 210
Aquaretic inhibits renal cancer proliferation: Role of vasopressin receptor-2 (V2-R). 205
Dialysis and the Elderly: An Underestimated Problem. 197
Concentration of circulating endothelial progenitor cells (EPC) in normal pregnancy and in pregnant women with diabetes and hypertension 193
Sevalamer Hydrochloride, Sevelamer Carbonate and Lanthanum Carbonate: In Vitro and In Vivo Effects on Gastric Environment 192
Aquaporin-2 (AQP2) urinary excretion and assumption of water with different mineral content in healthy subjects 180
Caffeine and the kidney: What evidence right now? 178
Correlation between quality of life assessment and a personality neurobiologic model in dialyzed patients 176
T and B lymphocytes: Chromosomic damage induced by hemodiafiltration. 175
Acute cardiovascular complications of hemodialysis. 175
Kidney disease and psoriasis: novel evidences beyond old concepts 175
Impaired antiviral activity of monocytes from patients on hemodiafiltration 173
Dialysis-related genotoxicity: Sister chromatid exchanges and DNA lesions in T and B lymphocytes of uremic patients - Genomic damage in patients on hemodiafiltration 169
Effects of haemodialysis on circulating endothelial progenitor cell count 169
Cardiovascular risk impairs circulating endothelial progenitor cells mobilization during a haemodialytic session 168
Effect of immunoglobulin treatment on endothelial progenitor cells in systemic lupus erythematosus 166
Peripheral blood CD34+ cells as a novel and noninvasive early marker of first trimester miscarriage: results from a case-control analysis 166
The erythropoietin and regenerative medicine: a lesson from fish 165
Cinacallcet modifies the pH of solutions in vitro: possible implications for gastro-intestinall side effects in vivo 165
Circulating endothelial progenitor cell mobilization in centenarians: a powerful source for extended renal life. 165
Analysis of antiviral activity in monocytes obtained from dialysis patients 162
Arrhythmias and hemodialysis: role of potassium and new diagnostic tools. 161
Aquaretic agents: What's beyond the treatment of hyponatremia? 160
Effect of two different models of hemodiafiltration potassium removal on QT dispersion 156
A case-by-case protocol of membranous nephropathy treatment with endovenous infusion of high doses of human immunoglobulins 156
Nephro-oncology: a link in evolution 154
Circulating progenitor cells after cold pressor test in hypertensive and uremic patients 153
The effect of two different protocols of potassium haemodiafiltration on QT dispersion 151
Erythropoietin and its lost receptor [8] 148
Neurobiological model and quality of life in discovering personality of the uremic patient. 147
Therapy with vasopressin receptor antagonists: the aquaretics 146
Renal complications in oncohematologic patients. 144
Erythropoietin and its lost receptor. 144
Neutrophil Gelatinase-Associated Lipocalin (NGAL) and progression of chronic kidney disease. 140
Neutrophil gelatinase-associated lipocalin (NGAL) as a marker of kidney damage 137
Pregnancy in uremic patients: An eventful journey 136
Genomic damage in endothelial progenitor cells from uremic patients in hemodialysis 135
Neutrophil gelatinase-associated lipocalin (NGAL) in human neoplasias: a new protein enters the scene. 135
Neutrophil gelatinase-associated lipocalin as an early biomarker of nephropathy in diabetic patients. 134
Neutrophil gelatinase-associated lipocalin (NGAL): a new piece of the anemia puzzle? 129
Management of patients after renal graft loss: an open question for nephrologists. 126
Neutrophil gelatinase-associated lipocalin reflects the severity of renal impairment in subjects affected by chronic kidney disease 125
Erythropoiesis and chronic kidney disease–related anemia: From physiology to new therapeutic advancements 125
Pathological and prognostic value of urinary neutrophil gelatinase-associated lipocalin in macroproteinuric patients with worsening renal function 119
Perioperative iloprost and endothelial progenitor cells in uremic patients with severe limb ischemia undergoing peripheral revascularization. 118
Neutrophil gelatinase-associated lipocalin (NGAL) reflects iron status in haemodialysis patients 117
Experimental therapies in renal replacement: The effect of two different potassium acetate-free biofiltration protocols on striated muscle fibers 117
Exploring the effects of DPP-4 inhibitors on the kidney from the bench to clinical trials 105
Neutrophil gelatinase-associated lipocalin in patients with autosomal-dominant polycystic kidney disease. 104
Preeclampsia and cardiovascular risk: general characteristics, counseling and follow-up. 104
Urinary Neutrophil Gelatinase-Associated Lipocalin (NGAL) is associated with severity of renal disease in proteinuric patients 102
Genomic damage in endothelial progenitor cells from uremic patients. 102
Endothelial progenitor cells at the interface of chronic kidney disease: from biology to therapeutic advancement 100
Pulmonary hypertension and erythropoietin. 99
Parathyroid hormone variability parameters for identifying high turnover osteodystrophy disease in hemodialysis patients: An observational retrospective cohort study 93
Parathyroid hormone and mobilization of circulating bone marrow-derived cells in uremic patients. 92
Variations of macular thickness after haemodialysis. A study using optical coherence tomography (OCT) 90
From kidney to cardiovascular diseases: NGAL as a biomarker beyond the confines of nephrology. 89
Endothelial progenitor cells: pathogenetic role and therapeutic perspectives 87
Neutrophil gelatinase-associated lipocalin levels in chronic haemodialysis patients. 82
Wernicke-Korsakoff Syndrome in End-Stage Renal Disease: A Case Report 81
Osteoprotegerin and carotid atherosclerosis in dialysis patients: An imaging (ECO-Doppler) and genic expression study 77
NGAL: a new missing link between inflammation and uremic anemia? 76
Restoring the dysfunctional endothelium 72
Haemodialysis: An Interesting Experimental Model 70
Renal Concerns in the Treatment of Chronic Hepatitis B with Tenofovir 67
Neutrophil gelatinase-associated lipocalin in the intensive care unit: time to look beyond a single, threshold-based measurement? 66
Increased plasma neutrophil gelatinase-associated lipocalin levels predict mortality in elderly patients with chronic heart failure. 41
null 39
null 20
null 16
Totale 9.211
Categoria #
all - tutte 30.464
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 30.464


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202121 0 0 0 0 0 0 0 0 0 0 0 21
2021/2022476 3 67 4 17 30 4 20 10 4 92 71 154
2022/20231.415 127 148 58 130 107 130 7 82 569 6 38 13
2023/2024278 27 49 14 28 23 73 2 19 0 7 4 32
2024/20251.422 26 12 40 92 38 55 34 259 359 126 141 240
2025/20264.381 254 307 309 273 392 900 520 558 564 142 79 83
Totale 9.211